Type
Sell
Instrument
LALPATHLAB
Entry Price
₹2,311
Price@Trade
₹2,318.55
Target Price
₹2,266
Stop Price
₹2,355
Valid Till
Jan 15, 2021 3:20 AM
Margin
₹231,100 approx for 100 Qty
Status
Exited
Exit Price
₹2,295.3
Net P&L
+₹1,570 (+0.68%)
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
LALPATHLAB
2,232
-63.45 (-2.76%)
Updated 03:28 18/01 IST
LALPATHLAB Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for LALPATHLAB
Disclaimer0% Bullish
0% Bearish
LALPATHLAB Buy or Sell - Brokerage Reports
No. of reports in last year
3
No. of analysts
1
Average Consensus Forecast
1232.67
Consensus Potential
-104.13%
LALPATHLAB Ratings
Long term LALPATHLAB rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
3.5/5 (2 Ratings)
Find answers to all your questions on live LALPATHLAB message board: Is LALPATHLAB buy or sell? Should I buy LALPATHLAB shares? Why are LALPATHLAB shares falling? Should I invest in LALPATHLAB stock?
- Home
- LALPATHLAB Forum
LALPATHLAB Share Price Discussion
N
Reputation: 10,122 • Today 4:58 AM
Dr. Lal PathLabs Q3 PAT Seen Up 27.4% YoY To Rs. 54.1 Cr: Prabhudas Lilladher
Net Sales are expected to increase by 16.1 percent Y-o-Y (down 11.8 percent Q-o-Q) to Rs. 327.9 crore, according to Prabhudas Lilladher.
Net Sales are expected to increase by 16.1 percent Y-o-Y (down 11.8 percent Q-o-Q) to Rs. 327.9 crore, according to Prabhudas Lilladher.
Moneycontrol
Like
Reply
A
Reputation: 19,243 • Jan 12 3:09 AM
📍📍Thyrocare Technologies … significant business revival in Q3 . Positive for diagnostic stocks.. Expects positive for Lal Path, Metropolis
· Thyrocare says - significant business revival in Q3 after business activities resumed across all states. The non-Covid business in par...
Read more...
1
Reply
S
Reputation: 76,221 • Jan 10 1:10 AM
Lal path Labs CMP 2409
Lal path labs operates its own path labs, while collection centres are primarily run on a franchisee model. Though operations are spread across the country, northern India accounts for over 70% of total revenue.
Financial
- RO...
Read more...
2
Reply
S
Reputation: 76,221 • Jan 7 4:28 AM
Lal path Labs CMP 2409
Lal path labs operates its own path labs, while collection centres are primarily run on a franchisee model. Though operations are spread across the country, northern India accounts for over 70% of total revenue.
Financial
- RO...
Read more...
4
Reply
T
Reputation: 314,474 • Jan 7 7:27 AM
The stock gave trendline breakout in 15mins TF and broke 50EMA SUPPORT in 2HRS TF. Wait for the confirmation.
Like
Reply
R
Reputation: 8,713 • Dec 21, 2020 8:54 AM
**FANTASTIC DAY END GUYS**
**NAUKRI 4600 TO 4400 (MET ALL TARGETS)**
**LAL PATHLAB 2213 TO 2260 (T3 HIT)**
**TORNTPHARMA EXITED CTC**
**BANK NIFTY T1 MET**
Like
Reply
R
Reputation: 8,713 • Dec 21, 2020 3:32 AM
RJ ROCKET TRADES in LALPATHLAB**BUY LAL PATH LAB AT CMP** **CMP 2213** **TG 2...
*AND PROFIT MORNING START GUYS WITH RJ TEAM**
**LALPATHLAB NON STOP GUYS**
**2260 FROM 2213**
**T1 HIT**
**T2 HIT**
**T3 HIT**
**ENJOY THE GAINS WITH RJ TEAM✈️✈️✈️✈️**
**BE READY FOR ANOTHER JACKPOT COMING UP NEXT**
Like
Reply
T
Reputation: 314,474 • Nov 28, 2020 4:58 AM
#LALPATHLAB WEEKLY CHART VIEW!!
Dr. Lal Pathlabs Ltd. is consolidating in an ascending triangle pattern and likely to see a breakout above swing high of 2395 level.
Technical parameters look positive as of now.
Immediate support comes at 2175 level.
Keep a close watch.
1
Reply
N
Reputation: 10,122 • Nov 23, 2020 4:01 AM
Add Dr. Lal Pathlabs, target price Rs 2430: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18504.65 Crore) operating in Hospitals & Allied Services sector.
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18504.65 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply
N
Reputation: 10,122 • Nov 17, 2020 5:26 AM
Buy Dr. Lal Pathlabs, target price Rs 2430: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18028.75 Crore) operating in Hospitals & Allied Services sector.
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 18028.75 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply
N
Reputation: 10,122 • Nov 6, 2020 10:36 AM
Dr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 cr
Revenue from operations stood at Rs 431.9 crore for the quarter under consideration. It was Rs 365.6 crore for the same period a year ago, it added.
Revenue from operations stood at Rs 431.9 crore for the quarter under consideration. It was Rs 365.6 crore for the same period a year ago, it added.
The Economic Times
Like
Reply
N
Reputation: 10,122 • Nov 6, 2020 9:03 AM
Dr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoY
Consolidated revenue for the said quarter came at Rs 431.9 crore, up 18 percent YoY from Rs 365.6 crore in the corresponding quarter of the previous financial year.
Consolidated revenue for the said quarter came at Rs 431.9 crore, up 18 percent YoY from Rs 365.6 crore in the corresponding quarter of the previous financial year.
Moneycontrol
Like
Reply
G
Reputation: 6,453 • Oct 24, 2020 3:01 AM
#LALPATHLAB MEDIUM TERM ABC BULLISH BO DONE TGT 2725/3359 SL 2050 ( WEEKLY CLBS )
Like
Reply
J
Reputation: 2,156 • Oct 23, 2020 8:39 AM
Post in Positional Trades (Swing,Momentum,Trending,Invest) channel on FrontPage
No access
No access
FrontPage
Like
Reply
A
Reputation: 19,243 • Oct 12, 2020 2:31 AM
Dr Lal Pathlabs has clarified that the data breach of patients was a result of misconfiguration in one of the company's minor web applications where temporary records were stored for operational purposes. It involved less than 0.5% of the records and the issue has been resolved s...
Read more...
Like
Reply
N
Reputation: 10,122 • Oct 9, 2020 2:23 AM
Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report
The data included patients’ booking details such as their name, address, phone number, email id, payment details, digital signature, and also the type of medical tests they had taken.
The data included patients’ booking details such as their name, address, phone number, email id, payment details, digital signature, and also the type of medical tests they had taken.
Moneycontrol
Like
Reply
N
Reputation: 10,122 • Oct 8, 2020 2:18 AM
Trade Spotlight: Metropolis Healthcare, Dr Lal Pathlabs & Ambuja Cement in focus
Dr Lal Pathlabs gained more than 11 percent, Metropolis Healthcare was up more than 4 percent and Ambuja Cement which hit a 52-week high closed with gains of more than 4 percent.
Dr Lal Pathlabs gained more than 11 percent, Metropolis Healthcare was up more than 4 percent and Ambuja Cement which hit a 52-week high closed with gains of more than 4 percent.
Moneycontrol
Like
Reply
J
Reputation: 2,156 • Oct 7, 2020 8:31 AM
LALPATHLAB 2300 16%up 🔥: Crossed all targets latest 2250, next 2500 Sl 2040
Today 2129-2300 🔥
Like
Reply
A
Reputation: 19,243 • Oct 7, 2020 4:34 AM
Buzzing Stock: Dr Lal Pathlabs Top gainer on the Nifty Midcap index Gains as much as 9.1% to Rs 2,178 Biggest single-day gain in over two years Trading at an all-time high Up for the third straight day Has gained over 15% in the last three trading sessions Saw breakout above 50-D...
Read more...
1
Reply
A
Reputation: 19,243 • Oct 7, 2020 4:27 AM
Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 l...
Read more...
2
Reply
N
Reputation: 10,122 • Sep 30, 2020 4:56 AM
Buy Dr. Lal Pathlabs, target price Rs 2142: ICICI Securities
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 15710.09 Crore) operating in Hospitals & Allied Services sector.
Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 15710.09 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Reply
P
Reputation: 10,193 • Sep 23, 2020 6:12 AM
Dr. Lal Pathlabs Ltd. is trading right at the weekly support zone.
Likely to see bounce in the short term until 1800 level is protected on the downside on closing basis.
Technical parameters looks positive as of now.
Keep a watch.
Like
Reply
A
Reputation: 19,243 • Sep 17, 2020 6:50 AM
Read more...
2
Reply (1)
See all replies
Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 l...
N
Reputation: 10,122 • Sep 14, 2020 5:08 AM
Select mid & smallcap stocks can provide the necessary alpha: Sacchitanand Uttekar
We expect markets to remain choppy throughout the week. Most of the price based evidence is pointing towards a broad range action within 11250-11750 with 11550 as its breakeven zone.
We expect markets to remain choppy throughout the week. Most of the price based evidence is pointing towards a broad range action within 11250-11750 with 11550 as its breakeven zone.
Moneycontrol
Like
Reply
N
Reputation: 10,122 • Sep 5, 2020 10:11 AM
Reopening of economy, increased testing, no mask use led to rise in COVID-19 cases in Delhi: Experts
The national capital has reported coronavirus cases in excess of 2,000 for four consecutive days since September 1. On Friday, the daily cases count stood at 2,914.
The national capital has reported coronavirus cases in excess of 2,000 for four consecutive days since September 1. On Friday, the daily cases count stood at 2,914.
The Economic Times
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
LALPATHLAB Share Price - Technicals
- NewsBotToday 4:58 AMDr. Lal PathLabs Q3 PAT Seen Up 27.4% YoY To Rs. 54.1 Cr: Prabhudas LilladherMoneycontrolNewsBotNov 23, 2020 4:01 AMAdd Dr. Lal Pathlabs, target price Rs 2430: ICICI SecuritiesThe Economic TimesNewsBotNov 6, 2020 10:36 AMDr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 crThe Economic TimesNewsBotNov 6, 2020 9:03 AMDr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoYMoneycontrolNewsBotOct 9, 2020 2:23 AMDr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: ReportMoneycontrolNewsBotSep 30, 2020 4:56 AMBuy Dr. Lal Pathlabs, target price Rs 2142: ICICI SecuritiesThe Economic TimesNewsBotSep 5, 2020 10:11 AMReopening of economy, increased testing, no mask use led to rise in COVID-19 cases in Delhi: ExpertsThe Economic TimesNewsBotAug 9, 2020 2:38 AM
Hold Dr. Lal PathLabs; target of Rs 1995: GeojitMoneycontrolNewsBotAug 8, 2020 6:13 AM
Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas LilladherMoneycontrolNewsBotJul 31, 2020 9:56 AM
Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 croreThe Economic Times
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.